November is Alzheimer’s Awareness Month. It’s a fitting time to look at the latest Israeli advances in preventing, diagnosing and treating the progressive and incurable brain disorder.
Alzheimer’s disease (AD) is the most common cause of the 9.9 million new cases of dementia diagnosed each year worldwide. The disease primarily strikes the elderly population, affecting 30 percent of those over age of 85.
AD impacts memory, thinking and language skills, and even the ability to carry out simple tasks.